The tumor-draining lymph nodes (TDLNs) are the primary sites of the development of anti-
tumor immunity. Primary tumor irradiation promotes 'radio-vaccination'by enhancing the …

More than 40% of men with intermediate-risk or high-risk prostate cancer will experience a
biochemical recurrence after radical prostatectomy. Clinical guidelines for the management …

Background Randomised trials have investigated various androgen deprivation therapy
(ADT) intensification strategies in men receiving radiotherapy for the treatment of prostate …

METHODS An exhaustive review of available literature was performed using the PubMed
database. Publications pertaining to hypofractionated radiotherapy and cost-effectiveness …

Background and purpose 1.5 Tesla magnetic resonance imaging radiotherapy linear
accelerator (MR-Linac) is gaining interest for treatment of localized prostate cancer. Clinical …

The underlying concept of precision medicine is simple. DNA is sequenced from tumour
biopsies, genetic (and potentially epigenetic) changes that promote the proliferation and …

Prostate cancer is the most commonly diagnosed cancer among men around the world.
Radiotherapy is a standard of care treatment option for men with localized prostate cancer …

PURPOSE Sufficient radiotherapy (RT) capacity is essential to delivery of high-quality
cancer care. However, despite sufficient capacity, universal access is not always possible in …

Background: Conventionally fractionated radiotherapy is a common treatment for men with
localized prostate cancer. A growing consensus suggests that stereotactic body radiation …

In recent years, stereotactic body radiation therapy (SBRT) has gained popularity among
clinical methods for the treatment of medium and low risk prostate cancer (PCa), mainly as …